LITERATURE SUMMARIES, ASSESSMENTS, FOR BEST PHARMACEUTICALS FOR CHILDREN ACT

《最佳儿童药物法案》的文献总结、评估

• 批准号: 7937131
• 负责人: KAREN HANSEN
• 金额: $ 7.5万
• 依托单位: CCS ASSOCIATES, INC.
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-09-30 至 2010-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7937131
• 关键词: LITERATURE; SUMMARIES; ASSESSMENTS; BEST; PHARMACEUTICALS

The NICHD, as delegated by the NIH, is responsible for implementing the Congressionally-mandated Best Pharmaceuticals for Children Act of 2002, as reauthorized in 2007. The NICHD is responsible for the performance of clinical trials of priority, ¿off patent¿ drugs that are used in children but that lack sufficient pediatric labeling. NICHD responsibility includes administrative activities as well as support, and coordinating support and participation of other ICs in BPCA activities. The function of this project is to provide literature summaries, assessments, and meta-analysis for the BPCA. Data used to conduct pharmacology studies in children.

NICHD由NIH授权，负责实施国会授权的2002年儿童最佳药物法案，并于2007年重新授权。NICHD负责优先临床试验的执行，用于儿童但缺乏足够儿科标签的非专利药物。国家排雷中心的职责包括行政活动以及支持、协调支持和其他国际中心参与BPCA活动。该项目的功能是为BPCA提供文献总结、评估和荟萃分析。用于在儿童中进行药理学研究的数据。